Akanda Corp. Announces Subsequent Registered Direct Offering

2 years ago

London, United Kingdom--(Newsfile Corp. - May 17, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical…

Akanda Announces Closing of Registered Direct Offering

2 years ago

London, United Kingdom--(Newsfile Corp. - May 17, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical…

Provation Partners With Al Naghi Medical in the UAE for Its Market-Leading Clinical Productivity Solution

2 years ago

Provation® MD enables clinicians to experience effortless clinical documentation with market-leading, on-premise procedure documentation solution improving efficiencies and quality of…

Avenir Wellness Solutions Reports Fourth Quarter 2023 Results

2 years ago

New Initiatives Showing Encouraging ResultsSHERMAN OAKS, CA / ACCESSWIRE / May 17, 2024 / Avenir Wellness Solutions, Inc. (OTCQB:AVRW) ("Avenir"…

Free LASIK for Professional Referees Across the NFL, NBA, MLB, NHL, MLS, USNT, WNBA, and NWSL

2 years ago

The LASIK.com Network is excited to announce their "Better Vision, Better Calls" initiative to offer free Modern LASIK eye surgery…

Covalon Presents Compassionate Care Technology at the Infusion Nurses Society (INS) Annual Meeting & Exhibition in Kansas City, MO

2 years ago

Visit Covalon at booth 420 to discover the latest in compassionate vascular access solutionsMISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company"…

Cosmos Health Participated in Vitafoods Europe 2024; Receives Significant Interest and Numerous New Partnership Inquiries for its Sky Premium Life Nutraceuticals Brand

2 years ago

CHICAGO, IL / ACCESSWIRE / May 17, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

NervGen Pharma to Present Two Posters at the American Spinal Injury Association 51st Annual Scientific Meeting

2 years ago

Vancouver, British Columbia--(Newsfile Corp. - May 17, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF), a clinical-stage biotech company…

Dermata Therapeutics Announces Exercise of Warrants for $2.66 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

2 years ago

SAN DIEGO, CA / ACCESSWIRE / May 17, 2024 / Dermata Therapeutics, Inc. (Nasdaq:DRMA)(Nasdaq:DRMAW) ("Dermata," or the "Company"), a late-stage…

Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024

2 years ago

LAVAL, QC / ACCESSWIRE / May 17, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix…